STOKStoke Therapeutics, Inc.
What is the market doing?
The market is leaning against it: in a downtrend (−22% vs 200-day) and a crowded short (+18% of shares).
In a downtrend, below its 50- and 200-day averages. Price is −22% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
A crowded short, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How STOK is trading
Stoke Therapeutics, Inc. is +7.9% over the past year while the S&P 500 is +18%: 10 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −22%
vs 200-day average · a clear downtrend
- RSI (14)
- 33
RSI (14) · neutral
- Below its 52-week high
- 36%
Below its 52-week high
Details›
- Last close2026-10-09
- $24.71
- 1 monthS&P 500 +2.7%
- −16%
- 1 yearS&P 500 +18%
- +7.9%
- 5 yearsS&P 500 +88%
- +3.3%
- vs 50-day average$29.36
- −16%
- 52-week high
- $38.35
- 52-week low
- $22.37
- Annualised volatility
- 64%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$647K
| Year | Return |
|---|---|
| 2026 (year to date) | −22% |
| 2025 | +188% |
| 2024 | +110% |
| 2023 | −43% |
| 2022 | −62% |
| 2021 | −61% |
| 2020 | +119% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 7 | 2 of 7 | −3.4% |
| Feb | 7 | 3 of 7 | +3.9% |
| Mar | 7 | 2 of 7 | +1.1% |
| Apr | 7 | 3 of 7 | −3.0% |
| May | 7 | 4 of 7 | +13% |
| Jun | 7 | 2 of 7 | −2.2% |
| Jul | 8 | 4 of 8 | −3.7% |
| Aug | 8 | 5 of 8 | +13% |
| Sep | 8 | 2 of 8 | −11% |
| Oct | 8 | 5 of 8 | +9.0% |
| Nov | 7 | 3 of 7 | −2.5% |
| Dec | 7 | 5 of 7 | +12% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.